Clinical Trials Directory

Trials / Completed

CompletedNCT02190409

An Invivo Study to Compare the Stability of Dental Implants With or Without Platelet Rich Fibrin Application

The Effect Of Platelet Rich Fibrin on Implant Stability

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
ELİF ONCU · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was to evaluate the effects of (Platelet Rich Fibrin) PRF application on implant osseointegration in the early phase of healing.

Detailed description

Objectives:Achieving accelerated implant osseointegration could provide immediate or early loading of implants. Platelet-rich fibrin (PRF) is widely used to accelerate soft and hard tissue healing. Activated platelets in PRF release growth factors resulting in cellular proliferation, collagen synthesis and osteoid production. The aim of this study was to compare the stability of dental implants inserted with one-stage surgical protocol with or without PRF application. Design: Non-randomized, Active Controlled Trial. Material and Methods: Twenty healthy patients (n=10 test group, n= control group) with adequate alveolar bone, having 2 or more adjacent missing teeth, extracted at least 6 months ago were included in this study. Minimum two tapered implants (Ankylosis, DentsplyFriadent) were placed to each patient. After surgical preparation of implant sockets, PRF that was prepared preoperatively was placed randomly to one of the sockets (PRF+). Acellular plasma portion of PRF was used to wet the implant placed into the PRF-coated socket. Resonance frequency measurements were made by Osstell ISQ after placement of implants, at 1 week and one month postoperatively. Key Words: Dental implant stability, Platelet Rich Fibrin, Resonance frequency analysis

Conditions

Interventions

TypeNameDescription
DEVICEDental implantThis longitudinal human clinical trial is designed to measure implant stability with the resonance frequency analyzer (Osstell, Integration Diagnostics AB, Sweden) at time of implant placement and up to 4 weeks post placement. delivered. No further follow-up will be done with the resonance frequency approach

Timeline

Start date
2011-12-01
Primary completion
2012-01-01
Completion
2012-12-01
First posted
2014-07-15
Last updated
2014-07-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02190409. Inclusion in this directory is not an endorsement.